SRTA logo

SRTA
Strata Critical Medical Inc

264
Mkt Cap
$376.66M
Volume
521,729.00
52W High
$6.02
52W Low
$2.51
PE Ratio
-23.81
SRTA Fundamentals
Price
$4.49
Prev Close
$4.33
Open
$4.35
50D MA
$4.42
Beta
1.80
Avg. Volume
856,507.82
EPS (Annual)
-$0.1906
P/B
1.40
Rev/Employee
$328,021.63
$336.68
Loading...
Loading...
News
all
press releases
Cathie Wood's Ark keeps selling one stock once again
Cathie Wood, head of Ark Investment Management, is known for making bold, conviction-driven bets, but she's just as quick to trim positions when the strategy shifts. That pattern is playing out again...
TheStreet.com·21h ago
News Placeholder
More News
News Placeholder
Strata Critical Medical (NASDAQ:SRTA) Upgraded to Hold at Zacks Research
Zacks Research raised Strata Critical Medical to a "hold" rating in a research report on Thursday...
MarketBeat·19d ago
News Placeholder
Strata Critical Medical (NASDAQ:SRTA) Now Covered by Analysts at Craig Hallum
Craig Hallum assumed coverage on Strata Critical Medical in a research report on Wednesday. They issued a "buy" rating and a $8.00 price objective on the stock...
MarketBeat·22d ago
News Placeholder
Strata Critical Medical (SRTA) Earnings Call
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·1mo ago
News Placeholder
Earnings Outlook For Strata Critical Medical
read more...
Benzinga·1mo ago
News Placeholder
AMN Healthcare Services (AMN) Beats Q3 Earnings and Revenue Estimates
AMN Healthcare (AMN) delivered earnings and revenue surprises of +105.26% and +3.15%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
News Placeholder
Biodesix, Inc. (BDSX) Reports Q3 Loss, Tops Revenue Estimates
Biodesix (BDSX) delivered earnings and revenue surprises of +27.50% and +2.68%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
News Placeholder
Strength Seen in Teladoc (TDOC): Can Its 6.3% Jump Turn into More Strength?
Teladoc (TDOC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·6mo ago
News Placeholder
JOBY or EVTL: Which eVTOL Stock Possesses an Edge Currently?
Vertical Aerospace edges past Joby Aviation with stronger finances, milestones, and stock performance in the fast-growing eVTOL space.
Zacks·7mo ago
News Placeholder
The Zacks Analyst Blog Highlights Joby Aviation, Archer Aviation and Strata Critical Medical
Joby Aviation's eVTOL progress and Blade buyout fuel optimism, but overvaluation and commercialization risks make JOBY a Sell-rated stock.
Zacks·7mo ago
<
1
2
...
>

Latest SRTA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.